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Background/aim: Lipid emulsions are promising as a potential new therapy for severe verapamil overdose. Our purpose is to draw
attention to the choice of solution by investigating the efficacy of intralipid 20% or medialipid 20% in verapamil overdose.
Materials and methods: Eighteen adult Sprague Dawley rats were randomly divided into three groups: control (saline; Group C),
intralipid 20% (Group I), and medialipid 20% (Group M). Rats were anesthetized with ketamine. Blood gas analysis, baseline heart
rate (HRb), and mean arterial pressure (MAPb) were evaluated. Verapamil at 2.5 mg kg–1 min–1 was infused until the HRb and MAPb
decreased by 50% and the times to HR0 and MAP0 were recorded. Treatment solutions of the groups were administered as 12.4 mL kg–1
in 5 min.
Results: While HR did not show a difference, MAP showed statistically significant differences among the groups. Intralipid 20% was
more efficient than the other two treatments at an early stage; however, as the administration time progressed, medialipid 20% also
turned out to be more efficient than the control treatment.
Conclusion: Our findings indicate that in a toxicity model of rats produced with verapamil, intralipid 20% and medialipid 20% solutions
partially eliminate cardiac-depressant effects and increase the survival rate.
Key words: Verapamil, toxicity, cardiovascular collapse, intralipid, medialipid

1. Introduction
Verapamil is a calcium channel blocker with a potent
negative inotropic effect used in the treatment of cardiac
disorders such as hypertension, cardiac arrhythmias, heart
rate control, and angina pectoris, as well as for cluster
headaches and migraines. Toxicity due to verapamil
overdose is generally fatal. Dysrhythmia, bradycardia,
and hypotension due to sinoatrial node depression
are common toxic symptoms. Supportive approaches,
inotropic agents, and drugs such as calcium, insulin, and
glucagon are standard treatment approaches (1).
Intravenous lipid emulsions are an important part
of total parenteral nutrition. Protective and life-saving
effects of intralipid 20% against the cardiotoxic effects of
bupivacaine have been proved by experimental studies
(2–5) and case presentations (6–8), and those effects
have been applied in treatment protocols (9). In studies
regarding overdose of verapamil, having a highly lipophilic
characteristic, it has been reported that intralipid 20%
might contribute to treatment. Lipid emulsions are
* Correspondence: sertcelebi@hotmail.com
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promising as a potential new therapy for severe verapamil
overdose (10,11).
This experimental study was designed to compare
the therapeutic efficacy of intralipid 20% (long-chain
triglyceride, LCT) and medialipid 20% (long- and
medium-chain triglyceride, LCT/MCT) emulsions on
verapamil toxicity. Our objective is to determine the
efficacy of these two lipid emulsions when cardiotoxicity
symptoms develop in a verapamil toxicity model in rats,
without administering standard treatment medication,
and to discuss the importance of solution choice.
2. Materials and methods
This study was performed at the Gazi University Faculty
of Medicine Experimental Animals Research Center,
Ankara, Turkey, with the approval of the Local Animal
Ethics Committee (GU.ET-166-24523, 20, 2012).
Eighteen adult Sprague Dawley rats weighing between
300 and 400 g were divided into three groups. The rats
were adapted to the environment by being kept at 20
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± 2 °C for 7 days, with 12 h in daylight and 12 h in the
dark. They were fed on standard pellet rat feed and water.
Anesthesia was performed with 50 mg/kg IM ketamine
(Ketalar, Pfizer, İstanbul, Turkey). Head and abdominal
fur were shaved, and rats were placed supine on a
heating blanket and their extremities were fixed. Rectal
temperature was monitored to maintain normothermia.
Needle electrodes were placed on the forefeet bilaterally
and the left rear foot. Electrocardiograms were recorded
in D2 derivation (MINDRAY Patient Monitor PM-8000
Express, Shenzhen MINDRAY Bio-Medical Electronics
Co. Ltd.). The tail vein was cannulated and the drugs
and liquids involved in the study were administered via
an infusion pump (Perfuser, B. Braun Melsungen AG,
Spase, Germany). Surgical tracheostomy was performed
by 16-G or 18-G IV cannula. For neuromuscular block,
0.1 mg kg–1 vecuronium (Blok-L, vecuronium bromide, 4
mg, Mustafa Nevzat İlaç Sanayi A.Ş., İstanbul, Turkey) was
administered as a bolus. Respiration was maintained at
100% O2, 4 L/min fresh gas flow, 12 mL kg–1 tidal volume,
and 40–55 breaths per minute via an automatic ventilator
(Harvard Rodent Model, Inspira ASV, Hollstone, MA,
USA). Invasive blood pressure was monitored though
cannulation of the abdominal aorta (SASAN Medical
Disposable Products Pressure Set, Ankara, Turkey).
The rats were randomly assigned to one of three groups
(six rats each): control (saline; Group C), intralipid 20%
(Group I; Intralipid 20%, Fresenius Kabi AB, Uppsala,
Sweden), and medialipid 20% (Group M; Lipofundin
MCT/LCT 20%, B. Braun Melsungen AG).
Following the completion of all the invasive procedures,
electrocardiograms and invasive blood pressure of the
rats were monitored for 10 min and the data belonging
to the 10th minute (Tb) heart rates (HRb) and mean
arterial pressure (MAPb) were recorded as baseline values.
Blood gas analysis was evaluated before the experiment
(NOVA Biomedical, Stat Profile, Critical Care Xpress,
Waltham, MA, USA). The experiment was then started by
administering verapamil (Isoptin, 5 mg in 2 mL, Abbott
Laboratories, Abbott Park, IL, USA) in a 2.5 mg kg–1 min–1
infusion in the groups. The times to reach 50% of HRb and
MAPb were marked as T0 and the data were recorded as
HR0 and MAP0. When MAP decreased by 50%, verapamil
infusion was stopped and treatment solutions, saline,
intralipid 20%, or medialipid 20%, were infused at 12.4
mL kg–1 in 5 min. Effects of treatment solutions on HR0
and MAP0 were recorded once every 5 min for the first 20
min (T0, T5, T10, T15, T20) and once every 10 min following
the first 20 min (T30, T40, T50, T60). Time of asystole was
recorded until the 60th minute, and if the rats did not die
at this time, intracardiac blood was removed.
Statistical analysis was performed using SPSS 18.0 for
Windows. Numerical variables are presented as mean ±
standard deviation. Whether there were differences among

the groups in terms of weight, pH, CO2, O2, and HCO3
was evaluated using the Kruskal–Wallis test. Differences
among the groups and within-group changes in terms of
HR and MAP were evaluated using a linear mixed model.
The level of statistical significance was determined as P <
0.05.
3. Results
The body weights (g) of the rats were similar. No statistically
significant differences were observed in baseline control
blood gas values (pH, PaCO2 mmHg, PaO2 mmHg, and
HCO3- mEq/L) (P > 0.05). MAPb was significantly higher
in Group I than in Group C and Group M, while MAPb was
lower in Group C than in Group M (P < 0.004) (Table 1).
Duration of infusion and the infused doses of verapamil
were similar among the groups (P > 0.05) (Table 2).
HR recorded at T5, T10, T15, T20, T30, T40, T50, and T60
did not show a significant difference (P = 0.304) according
to HR0 among the groups (Table 3). MAP and HR values
decreased significantly when compared to HR0 and MAP0
values within the groups (P < 0.001) (Tables 1 and 3).
When the values were evaluated at different time stages,
Group I was found to be significantly higher in all stages
between MAP10 and MAP60 than Group C. Group I was
only significantly higher in MAP10 when compared to
Group M. Group M was found to be significantly higher
than Group C in MAP15, MAP20, and MAP30 stages (Table
1). When the experiment ended (T60), the surviving
number of rats was 4, 2, and 3 and the rate of death was
66.6%, 33.3%, and 50% (P = 0.507) in Group C, Group I,
and Group M, respectively.
4. Discussion
In the present experimental study, lipid emulsions having
the same concentration but different formulations were
evaluated with regard to verapamil toxicity. When
assessed in terms of survival rate within 60 min, although
the intralipid 20% (33.3%) treatment seemed to be more
advantageous then medialipid 20% (50%) and saline
(66.7%), the expected benefit was not fully provided.
Verapamil is the most serious poisoning calcium
channel blocker that causes overdoses due to its
cardiodepressive effect. In the literature, there are
experimental studies in which different doses were used
to develop verapamil toxicity in rats (10,12–14). In this
study, the dose of verapamil was selected as 2.5 mg kg–1
min–1 based on the study by Magdalan (14). Tebbutt et
al. (10) showed the rats treated with intralipid 20% lived
longer than those in the control group and they stated
that intralipid 20% at 12.4 mL kg–1 was the minimum dose
for a mean length of life of 63 min in verapamil infusion.
Similarly, in the present study, the chosen volume of lipid
emulsions was 12.4 mL kg–1 in 5 min as soon as verapamil
infusion was stopped.
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Table 1. Mean arterial pressure values (mean ± standard deviation).
mmHg

Groups Control (n = 6)

Intralipid (n = 6)

Medialipid (n = 6)

P among groups

MAPb

73 ± 24.9

111.5 ± 26.6†

101 ± 12.2*

0.004

T0

34 ± 15

53.7 ± 14

45.7 ± 7.1

0.224

T5

10.3 ± 3.7

28.7 ± 22.6

18.3 ± 7

0.273

T10

14.3 ± 13.7

47.2 ± 31.6†

16 ± 14.1

0.007

T15

20 ± 22.1

52.3 ± 37.2‡

53 ± 34*

0.009

T20

19 ± 23.6

52 ± 37.7‡

59.7 ± 12.9*

0.007

T30

18.7 ± 23.1

63 ± 34.8‡

58.7 ± 15.6*

0.003

T40

20 ± 20.3

77 ± 8.8‡

52 ± 18.5

0.003

T50

21.7 ± 20.6

74.5 ± 10.5‡

46 ± 15.7

0.009

T60

28 ± 12.7

77.3 ± 13.1‡

44.3 ± 14.6

0.008

Within-group P

< 0.001

< 0.001

< 0.001

P < 0.05 is significant; MAP, Mean arterial pressure; T, time, b, baseline.
†Intralipid is higher than control and medialipid; ‡Intralipid is higher than control; *Medialipid is higher than control.
Table 2. Duration and doses of infusion of verapamil in groups (mean ± standard deviation).
Groups

Time (s)

Dose (mg)

Control (n = 6)

105.0 ± 45.5

1.4 ± 0.5

Medialipid (n = 6)

95.8 ± 27.3

1.3 ± 0.4

Intralipid (n = 6)

79.2 ± 16.9

1.1 ± 0.3

P > 0.05 for all parameters in all groups.
Table 3. Heart rate values in groups (mean ± standard deviation).
beats/min

Groups Control (n = 6)

Intralipid (n = 6)

Medialipid (n = 6)

HRb

232.8 ± 17.8

238.3 ± 33.7

251.3 ± 42.3

T0

159.8 ± 49.2

148.3 ± 18

175.3 ± 58

T5

125.3 ± 58.3

140 ± 29.4

126.5 ± 33.8

T10

118 ± 38.5

119 ± 44.7

95.3 ± 44.2

T15

104.3 ± 44

123 ± 43.4

86.8 ± 46.2

T20

90 ± 36.1

122 ± 52.7

116 ± 17.4

T30

96 ± 17.8

117.6 ± 57.2

115 ± 4

T40

83.7 ± 31,8

134 ± 35.4

102 ± 8.5

T50

70 ± 40.1

129.8 ± 35,3

88.7 ± 9

T60

80 ± 38.2

126.3 ± 36.7

82.3 ± 4.6

Within-group P

<0.001

<0.001

<0.001

P < 0.05 is significant; HR, Heart rate; T, time; b, baseline.

1570

P among groups
0.727
0.525
0.791
0.606
0.135
0.205
0.581
0.207
0.104
0.195
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There are many standard treatment approaches
for verapamil toxicity in humans; among these are
calcium, atropine, adrenaline, glucagon, amrinone,
4-aminopyridine, Bay K 8644, and insulin (13–16). French
et al. (17) reported that sufficient hemodynamic recovery
could not be obtained in a patient in shock due to verapamil
overdose although all supportive methods were used. They
observed that serum verapamil level decreased and MAP
increased following the administration of intralipid 20%.
It was also stated that the recovery of the patient cannot be
related only to intralipid.
Liang et al. (11) concluded that intravenous lipid
treatment was found to be effective in massive calcium
channel blocker overdose, and its early start in the case of
hemodynamic compromise was recommended.
In another study, it was reported that when intravenous
lipids were used along with standard treatment methods
such as atropine and calcium chloride, the increases in MAP
and survival rate were higher. The authors also pointed out
that drugs that do not interact with lipid solutions should
be selected as they do not affect intracellular fatty acids
and carbohydrate metabolism (18).
Jamaty et al. (19) stated that lipid emulsions decrease
mortality in cases of poisoning due to lipophilic agents;
however, since their reliability has not been proven yet,
they cannot replace common antidotes or supportive
special treatments in cardiotoxic agent poisoning.
The “Lipid Rescue” protocol recommended that in
cases of local anesthetic toxicity lipid rescue treatment
should be started as early as possible along with basic life
support, that epinephrine should not be administered at
more than 10 µg kg–1, and that vasopressin should not be
used (16). The question is whether this protocol is suitable
for cases of lipophilic drug toxicity. We are of the opinion
that lipid rescue should be done as soon as possible
together with known standard treatment approaches such
as calcium or insulin and glucose in verapamil toxicity.
Because of their cardiovascular effects depending on
their lipid components, lipid emulsion should be used with
caution. When compared with LCTs, MCTs have the same
superior qualifications. MCTs are absorbed, hydrolyzed,
and transported easily and make energy available rapidly,
and they have a smaller molecular size and greater water

solubility with very low tendency to be deposited as body
fat (20).
Contradictory views are also found in different studies.
Li et al. (21) reported that long-chain triglyceride emulsion
in rats for local anesthetic-induced cardiovascular collapse
showed superior hemodynamic recovery compared
to long- and medium-chain triglyceride emulsion. In
another study, the authors concluded that intravenous
infused lipid emulsion increased left ventricular pressure
via blockading the nitric oxide released from endothelial
cells and the positive inotropic effect of medialipid 20%
was found superior to intralipid 20% (22). However, in
cases where rapid administration of lipids at high volumes
would cause a risk, medialipid could be considered as an
alternative, and it could be administered in higher doses
than intralipid due to its molecular structure. In cases
where higher doses are required, medialipid 20% may be
considered.
The main limitation of this study is the small sample
size (six rats in each group). Another limitation is the
potential effects of ketamine, including stimulation of
the sympathetic tone, positive inotropic effects, and
ion channel blocking action (23). The occurrence of
differences in baseline MAP values among the groups is
another limitation of this study. Heavy blood loss during
the preparation of the some rats for the study might be an
explanation for this limitation. The similarity among the
groups in times and doses required in decreasing MAP
values by 50% eliminated this limitation. All data during
the treatment period were compared with this time (T0).
In conclusion, although the benefits of lipid rescue in
bupivacaine toxicity have been proved, the benefits of a
similar rescue protocol for verapamil should be discussed
and further studies are required to determine efficient doses
and combinations. Our findings indicate that in a toxicity
model of rats produced with verapamil, the supportive
hemodynamic effects of intralipid 20% and medialipid
20% emulsions do not show a significant difference. Both
of them partially eliminate cardiac-depressant effects and
increase the survival rate. We agree that lipid emulsions
also have supportive treatment effects in addition to the
standard treatment drugs for verapamil toxicity.
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